‘Extreme’ SABA overuse seen with pharmacy OTC inhalers
By Michael Woodhead
15 Aug 2019
Lax rules that allow people to buy asthma reliever inhalers in retail pharmacies without medical supervision is contributing to widespread overuse of short-acting beta-agonists (SABA), Australian research suggests. A survey of 412 people who bought a SABA inhaler over the counter from a retail pharmacy found that 289 (70%) were overusers, as defined by inhaler ...